Skip to Main Content

INFORMATION FOR

    Understanding Gene Editing

    February 12, 2025

    Transcript

    • 00:05Gene is a piece of
    • 00:06the DNA we call blueprint
    • 00:08for life.
    • 00:10DNA or gene give instruction
    • 00:13that goes to the mRNA,
    • 00:14then mRNA
    • 00:15translate to the protein.
    • 00:18The protein pretty much responsible
    • 00:20for all our biological
    • 00:22functions.
    • 00:23That's in how we work
    • 00:24because our protein.
    • 00:26Our gene determines which protein
    • 00:28to be expressed.
    • 00:30Every cell you have to
    • 00:31have
    • 00:32a sort of DNA
    • 00:34to make the cell functions.
    • 00:36But cells in different organs,
    • 00:37different tissues, they
    • 00:39express certain subset of genes.
    • 00:44The genetic variant can cause
    • 00:46called a personal trait,
    • 00:48which is neutral benign.
    • 00:50But some of them are
    • 00:51crucial for our health. If
    • 00:53that particular variant
    • 00:55end up in a very
    • 00:56critical part of the gene
    • 00:58We may produce a faulty
    • 01:00protein
    • 01:01or, you know, we cannot
    • 01:03produce a specific protein at
    • 01:05all.
    • 01:06That became disease causing. Oftentimes,
    • 01:09we commutation.
    • 01:10For some genetic disease, you
    • 01:12know,
    • 01:12the cause could be very
    • 01:14complicated. Without understanding the mechanism,
    • 01:16it's certainly very difficult to
    • 01:18design any, treatment.
    • 01:23Gene editing can modulate or
    • 01:25correct a gene,
    • 01:27which you believe in causing
    • 01:28disease.
    • 01:29It's a very powerful tool
    • 01:31which could be used to
    • 01:32produce the
    • 01:33the right form of protein,
    • 01:35which respond for most, biological
    • 01:38functions.
    • 01:39Before, there is no tool
    • 01:42can do this job very,
    • 01:43very efficiently.
    • 01:45Even somebody carries a genetic
    • 01:47variance,
    • 01:48this genetic variance may not
    • 01:49affect all cells or tissues.
    • 01:52When CRISPR coming, so this
    • 01:55became a reality.
    • 01:57So you can editing or
    • 01:58correct the gene very efficient
    • 02:00way.
    • 02:01Basically, you can target at
    • 02:03the specific cells.
    • 02:04So there's a lot of
    • 02:05advantages that makes CRISPR,
    • 02:08so revolutionary.
    • 02:09And then, you know, now
    • 02:10a lot of, people, including
    • 02:12us,
    • 02:13try to use this technology
    • 02:15to, you know, to treat
    • 02:16genetic disease.
    • 02:22Pretty much the biological structure
    • 02:24of the brain makes drug
    • 02:25delivery to the brain. This
    • 02:26case deliver genome medicines to
    • 02:28the brain. Very, very challenging.
    • 02:31This very innovative technology,
    • 02:33in short we call STAP,
    • 02:34allow
    • 02:35us to deliver
    • 02:37the crisp editing
    • 02:38more efficient
    • 02:40to the brain.
    • 02:42Basically, it's a technology based
    • 02:43on the use of small
    • 02:45molecules to deliver protein based
    • 02:47genome editing machinery.
    • 02:50We have developed a thousand
    • 02:52of stuff molecules already.
    • 02:54So we screen those stuff
    • 02:56molecules.
    • 02:57We found certain stuff molecules
    • 02:59like a specific cell type.
    • 03:02They enable,
    • 03:03deliver all the CRISPR machinery
    • 03:06into the brain and dispose
    • 03:08the swabs brain. So that's
    • 03:09very unique.
    • 03:12We have five thousand disease.
    • 03:13We know the mechanism,
    • 03:14but
    • 03:15each one may have a
    • 03:16different mechanism. So therefore,
    • 03:19individual disease, you may have
    • 03:22developed individual
    • 03:23sort of for the tool,
    • 03:24even under the umbrella for
    • 03:26the CRISPR editing.
    • 03:28So far, I think we
    • 03:29used the Cas9
    • 03:31for the disease we're working
    • 03:32on right now. It's Angelman
    • 03:34syndrome. That potentially can
    • 03:36apply to a few hundred
    • 03:38other new genetic disease.
    • 03:41Our hope is that in
    • 03:42the next few years with
    • 03:44the support from NIOSH,
    • 03:46we can move this stuff
    • 03:47based therapy into clinic.
    • 03:51But stuff technology is a
    • 03:52platform technology,
    • 03:54which means that we can,
    • 03:56potentially adapt this technology,
    • 03:58for deliver our other, payloads
    • 04:01to other cells and tissues.
    • 04:05That means in long term,
    • 04:06we hope, this technology
    • 04:08can be repurposed enough for
    • 04:10treatment of many other rare
    • 04:11disease.